7 stories found
Reports indicate that President Trump plans to fire FDA Commissioner Marty Makary, reportedly over his handling of abortion pill approvals, drug regulations, and vaccines. The move has drawn attention to the administration's priorities regarding the regulatory agency.
An article from the Wall Street Journal delves into what is being termed 'President Trump’s Marty Makary Problem', suggesting a specific issue or challenge involving the two figures.
The U.S. Food and Drug Administration has reversed its earlier decision and will now review Moderna's application for its modified influenza vaccine.
U.S. Food and Drug Administration Commissioner Marty Makary has defended the agency's drug approval decisions in an interview, following a wave of backlash.
FDA Dropping Requirement For 2 Studies For New Drug Approvals Authored by Zachary Stieber via The Epoch Times (emphasis ours), The Food and Drug Administration (FDA) will approve many new drugs based on one trial moving forward, agency leaders have said. FDA Commissioner Dr. Marty Makary in Washington on July 29, 2025. Saul Loeb/AFP via Getty Images The FDA has typically required two studies from companies seeking approval for most new drugs, although in recent years it has ap...
A report describes an environment of paranoia, turmoil, and backlash within the Food and Drug Administration (FDA) during the tenure of Marty Makary.
FDA chief Marty Makary addresses the contentious period for the agency, marked by significant staff and budget cuts, and discusses changes to vaccine policy and the use of compounded GLP-1s.